Collage photo of Yüksel Ürün and Payal Kapur/X
Jul 15, 2024, 08:57
Yüksel Ürün: Prognostic and predictive biomarkers in RCC by Payal Kapur
Yüksel Ürün, Medical Oncologist at Ankara University, shared a post on X:
“ Outstanding presentation at Kidney Cancer Research Summit 2024 (KCRS24).
- Numerous prognostic and predictive biomarkers in Renal Cell Carcinoma (RCC) by Payal Kapur.
- Gene expression-based angiogenic and inflamed RCC subtypes correlate with therapy response.
- Challenges in RNA signatures and potential of morphology in therapy selection.”
Source: Yüksel Ürün/X
Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 18:52
Mar 30, 2025, 18:31
Mar 30, 2025, 17:19